Otsuka Pharmaceutical and Ionis Pharmaceuticals said on Tuesday their experimental drug met the main ​goal of a late-stage study in patients ‌with a rare inherited form of amyotrophic lateral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results